These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 17162790

  • 1. Vaccine for Alzheimer's disease?
    Health News; 2006 Oct; 12(10):2. PubMed ID: 17162790
    [No Abstract] [Full Text] [Related]

  • 2. Toxicity of beta-amyloid vaccination in patients with Alzheimer's disease.
    Imbimbo BP.
    Ann Neurol; 2002 Jun; 51(6):794. PubMed ID: 12112091
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.
    Schenk D.
    Nat Rev Neurosci; 2002 Oct; 3(10):824-8. PubMed ID: 12360327
    [No Abstract] [Full Text] [Related]

  • 5. Hopes remain for an Alzheimer's vaccine.
    Schenk D.
    Nature; 2004 Sep 23; 431(7007):398. PubMed ID: 15385984
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Vaccination against Alzheimer's disease?].
    Zündorf I, Dingermann T.
    Pharm Unserer Zeit; 2008 Sep 23; 37(1):63. PubMed ID: 18081047
    [No Abstract] [Full Text] [Related]

  • 9. Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis.
    Lee EB, Leng LZ, Lee VM, Trojanowski JQ.
    FEBS Lett; 2005 May 09; 579(12):2564-8. PubMed ID: 15862291
    [Abstract] [Full Text] [Related]

  • 10. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B.
    Curr Opin Mol Ther; 2007 Feb 09; 9(1):79-85. PubMed ID: 17330405
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dangers of the amyloid-beta vaccination.
    Smith MA, Joseph JA, Atwood CS, Perry G.
    Acta Neuropathol; 2002 Jul 09; 104(1):110. PubMed ID: 12070672
    [No Abstract] [Full Text] [Related]

  • 13. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
    Matsuda J, Kaminaka K, Nozaki C.
    Biochem Biophys Res Commun; 2009 Apr 24; 382(1):149-52. PubMed ID: 19265678
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Good and bad amyloid antibodies.
    Mattson MP, Chan SL.
    Science; 2003 Sep 26; 301(5641):1847-9. PubMed ID: 14512605
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Abeta vaccination and treatment of Alzheimer's disease].
    Takeda K, Hara H.
    No To Shinkei; 2005 Oct 26; 57(10):867-76. PubMed ID: 16277231
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.